New Drugs for Rheumatism: The Present and Future of Rheumatism Therapy

By Charles Fleming and Annika Meyers

Rheumatism is a chronic disease that has a significant impact on the lives of millions of people worldwide. However, in recent decades, medical research has made significant progress in improving treatment options for sufferers. Today, we not only have proven drugs at our disposal, but also completely new therapeutic approaches that are revolutionizing the treatment of rheumatism.
The focus is not only on the successes of the past decades, but above all on the pioneering drugs that are currently in clinical research and development. From biologics and Janus kinase inhibitors to personalized therapy approaches: The book provides insights into the variety of therapy options and explains the role played by new approaches such as the blockade of cytokines or the use of targeted kinase inhibitors. It shows how the targeted use of biomarkers allows therapies to be tailored ever more precisely to individual patients and outlines the promising developments that are expected in the coming years.
This book offers a well-founded, yet easy-to-understand analysis of current and future possibilities in rheumatism therapy. It shows how modern drugs can help to alleviate the symptoms of rheumatism, improve quality of life and slow down the progression of the disease in the long term. For sufferers and specialists alike, this work is essential reading that not only provides information, but also gives hope for a better future for people with rheumatism.

• Format: Paperback
• Language: English
• ISBN: 3689049644
• ISBN13: 9783689049645
• Release Date: October 2024
• Publisher: Bremen University Press
• Length: 124 Pages
• Weight: 0.37 lbs.
• Dimensions: 0.3" x 5.5" x 8.5"